On 2025-05-14, Gain Therapeutics, Inc. (GANX) announced earnings per share of $-0.16 for the fiscal quarter ending 2025-03-31, meeting the average analyst estimate of $-0.16.
The next expected annoucement date for quarterly earnings is 2025-08-14, with an average estimated earnings per share of $-0.17 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-14 | 2025-03-31 | $-0.16 | $-0.16 |
| 2025-03-27 | 2024-12-31 | $-0.18 | $-0.11 |
| 2024-11-14 | 2024-09-30 | $-0.23 | $-0.17 |
| 2024-08-08 | 2024-06-30 | $-0.31 | $-0.42 |
| 2024-05-14 | 2024-03-31 | $-0.30 | $-0.22 |
| 2024-03-26 | 2023-12-31 | $-0.32 | $-0.29 |
| 2023-11-14 | 2023-09-30 | $-0.47 | $-0.37 |
| 2023-08-10 | 2023-06-30 | $-0.33 | $-0.62 |
| 2023-05-12 | 2023-03-31 | $-0.40 | $-0.43 |
| 2023-03-23 | 2022-12-31 | $-0.37 | $-0.39 |
| 2022-11-10 | 2022-09-30 | $-0.46 | $-0.38 |
| 2022-08-08 | 2022-06-30 | $-0.35 | $-0.43 |
| 2022-05-16 | 2022-03-31 | $-0.34 | $-0.28 |
| 2022-03-24 | 2021-12-31 | $-0.49 | $-0.25 |
| 2021-11-12 | 2021-09-30 | $-0.34 | $-0.39 |
| 2021-08-11 | 2021-06-30 | $-0.31 | $-0.30 |
| 2021-05-10 | 2021-03-31 | $-0.13 | $-0.50 |